Kessy Charles Shija, Alphonce Chandika, Masumbuko Mwashambwa, Alfred Meremo, Shuzo Kobayashi, Sumi Hidaka, Kazunari Tanabe, Awadh Mohomed, Devotha Mputi, Sabina Matulo Mmbali, Venance John Misago, Okoa Sukunala, Vitus Kajerero, Remigius Rugakingira, Reuben Mkinga, Ahmed Toure, Hindu Ibrahim, Denis Rainer, Anthony Gyunda, Nashon Kagwe, Christina Mwakilasa, Andason Kilovele, Abel Nkono Makubi
{"title":"资源匮乏国家的肾移植;坦桑尼亚本杰明·姆卡帕医院6年的成功与挑战。","authors":"Kessy Charles Shija, Alphonce Chandika, Masumbuko Mwashambwa, Alfred Meremo, Shuzo Kobayashi, Sumi Hidaka, Kazunari Tanabe, Awadh Mohomed, Devotha Mputi, Sabina Matulo Mmbali, Venance John Misago, Okoa Sukunala, Vitus Kajerero, Remigius Rugakingira, Reuben Mkinga, Ahmed Toure, Hindu Ibrahim, Denis Rainer, Anthony Gyunda, Nashon Kagwe, Christina Mwakilasa, Andason Kilovele, Abel Nkono Makubi","doi":"10.1186/s12882-025-04284-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Kidney transplantation (KT) is the optimal treatment for end-stage renal disease (ESRD), requiring multidisciplinary expertise, infrastructure, and reliable access to immunosuppression. This review examines the establishment and sustainability of a KT program at Benjamin Mkapa Hospital (BMH) in Tanzania since its inception in 2018 through a collaboration with Tokushukai Medical group (TMG) from Japan, highlighting successes, challenges, and long-term prospects.</p><p><strong>Methodology: </strong>We retrospectively reviewed the methods employed to establish the KT program and analysed data from 37 KT recipients transplanted between March 2018 and July 2024. Statistical analysis (SPSS version 27) yielded median and proportions, and Kaplan-Meier survival curves for patients' survival and graft survival.</p><p><strong>Results: </strong>BMH successfully established a KT program with TMG collaboration, training 11 medical personnel. The main challenges encountered were shortage of trained staff, inconsistent supply of medical resources and immunosuppressive drugs, long turnaround times for outsourced histocompatibility tests, funding limitations, and a scarcity of kidney donors. Among 37 analysed recipients (70% male, median age 50 years with IQR: 39-56), hypertension (43%) and diabetes (32.5%) were the leading causes of ESRD. The majority of donors were blood-related (84%), with 16% being spouses. Graft survival rates at 1, 3, and 5 years were 94%, 90%, and 90%, respectively, while patient survival rate at 1,3 and 5 were 97%, 81%, and 81%, respectively. The overall estimated mortality rate was 37.3 (95%CI: 14.0-99.4) per 1000 person per years.</p><p><strong>Conclusion: </strong>BMH has successfully sustained a KT program led by a local team following training and mentorship from Japanese experts. The overall estimated mortality rate indicated favourable outcomes for kidney transplant recipients in this low-resource setting comparable to those in developed nations. The hospital's six-year experience demonstrates the feasibility of establishing and maintaining KT services in low-income countries.</p>","PeriodicalId":9089,"journal":{"name":"BMC Nephrology","volume":"26 1","pages":"525"},"PeriodicalIF":2.4000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12465639/pdf/","citationCount":"0","resultStr":"{\"title\":\"Kidney transplant in low resources countries; 6 years of successes and challenges at Benjamin Mkapa Hospital, Tanzania.\",\"authors\":\"Kessy Charles Shija, Alphonce Chandika, Masumbuko Mwashambwa, Alfred Meremo, Shuzo Kobayashi, Sumi Hidaka, Kazunari Tanabe, Awadh Mohomed, Devotha Mputi, Sabina Matulo Mmbali, Venance John Misago, Okoa Sukunala, Vitus Kajerero, Remigius Rugakingira, Reuben Mkinga, Ahmed Toure, Hindu Ibrahim, Denis Rainer, Anthony Gyunda, Nashon Kagwe, Christina Mwakilasa, Andason Kilovele, Abel Nkono Makubi\",\"doi\":\"10.1186/s12882-025-04284-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Kidney transplantation (KT) is the optimal treatment for end-stage renal disease (ESRD), requiring multidisciplinary expertise, infrastructure, and reliable access to immunosuppression. This review examines the establishment and sustainability of a KT program at Benjamin Mkapa Hospital (BMH) in Tanzania since its inception in 2018 through a collaboration with Tokushukai Medical group (TMG) from Japan, highlighting successes, challenges, and long-term prospects.</p><p><strong>Methodology: </strong>We retrospectively reviewed the methods employed to establish the KT program and analysed data from 37 KT recipients transplanted between March 2018 and July 2024. Statistical analysis (SPSS version 27) yielded median and proportions, and Kaplan-Meier survival curves for patients' survival and graft survival.</p><p><strong>Results: </strong>BMH successfully established a KT program with TMG collaboration, training 11 medical personnel. The main challenges encountered were shortage of trained staff, inconsistent supply of medical resources and immunosuppressive drugs, long turnaround times for outsourced histocompatibility tests, funding limitations, and a scarcity of kidney donors. Among 37 analysed recipients (70% male, median age 50 years with IQR: 39-56), hypertension (43%) and diabetes (32.5%) were the leading causes of ESRD. The majority of donors were blood-related (84%), with 16% being spouses. Graft survival rates at 1, 3, and 5 years were 94%, 90%, and 90%, respectively, while patient survival rate at 1,3 and 5 were 97%, 81%, and 81%, respectively. The overall estimated mortality rate was 37.3 (95%CI: 14.0-99.4) per 1000 person per years.</p><p><strong>Conclusion: </strong>BMH has successfully sustained a KT program led by a local team following training and mentorship from Japanese experts. The overall estimated mortality rate indicated favourable outcomes for kidney transplant recipients in this low-resource setting comparable to those in developed nations. The hospital's six-year experience demonstrates the feasibility of establishing and maintaining KT services in low-income countries.</p>\",\"PeriodicalId\":9089,\"journal\":{\"name\":\"BMC Nephrology\",\"volume\":\"26 1\",\"pages\":\"525\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12465639/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12882-025-04284-z\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12882-025-04284-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:肾移植(KT)是终末期肾病(ESRD)的最佳治疗方法,需要多学科专业知识、基础设施和可靠的免疫抑制途径。本综述通过与日本Tokushukai医疗集团(TMG)合作,审查了坦桑尼亚Benjamin Mkapa医院(BMH)自2018年成立以来的KT项目的建立和可持续性,重点介绍了成功、挑战和长期前景。方法:我们回顾性地回顾了建立KT计划所采用的方法,并分析了2018年3月至2024年7月间移植的37名KT受者的数据。统计分析(SPSS version 27)得出患者生存和移植物生存的中位数和比例,以及Kaplan-Meier生存曲线。结果:BMH与TMG合作成功建立了KT项目,培训了11名医护人员。遇到的主要挑战是缺乏训练有素的工作人员,医疗资源和免疫抑制药物供应不稳定,外包组织相容性测试的周转时间长,资金限制以及肾脏捐赠者稀缺。在分析的37名接受者中(70%为男性,中位年龄50岁,IQR: 39-56),高血压(43%)和糖尿病(32.5%)是ESRD的主要原因。大多数献血者是血亲(84%),其中16%是配偶。移植物1年、3年和5年的生存率分别为94%、90%和90%,而患者1年、3年和5年的生存率分别为97%、81%和81%。总体估计死亡率为每1000人每年37.3人(95%CI: 14.0-99.4)。结论:BMH在日本专家的培训和指导下,成功地维持了一个由当地团队领导的KT项目。总体估计死亡率表明,在这个资源匮乏的环境中,肾移植受者的预后与发达国家相当。该医院六年的经验表明,在低收入国家建立和维持传统医疗服务是可行的。
Kidney transplant in low resources countries; 6 years of successes and challenges at Benjamin Mkapa Hospital, Tanzania.
Background: Kidney transplantation (KT) is the optimal treatment for end-stage renal disease (ESRD), requiring multidisciplinary expertise, infrastructure, and reliable access to immunosuppression. This review examines the establishment and sustainability of a KT program at Benjamin Mkapa Hospital (BMH) in Tanzania since its inception in 2018 through a collaboration with Tokushukai Medical group (TMG) from Japan, highlighting successes, challenges, and long-term prospects.
Methodology: We retrospectively reviewed the methods employed to establish the KT program and analysed data from 37 KT recipients transplanted between March 2018 and July 2024. Statistical analysis (SPSS version 27) yielded median and proportions, and Kaplan-Meier survival curves for patients' survival and graft survival.
Results: BMH successfully established a KT program with TMG collaboration, training 11 medical personnel. The main challenges encountered were shortage of trained staff, inconsistent supply of medical resources and immunosuppressive drugs, long turnaround times for outsourced histocompatibility tests, funding limitations, and a scarcity of kidney donors. Among 37 analysed recipients (70% male, median age 50 years with IQR: 39-56), hypertension (43%) and diabetes (32.5%) were the leading causes of ESRD. The majority of donors were blood-related (84%), with 16% being spouses. Graft survival rates at 1, 3, and 5 years were 94%, 90%, and 90%, respectively, while patient survival rate at 1,3 and 5 were 97%, 81%, and 81%, respectively. The overall estimated mortality rate was 37.3 (95%CI: 14.0-99.4) per 1000 person per years.
Conclusion: BMH has successfully sustained a KT program led by a local team following training and mentorship from Japanese experts. The overall estimated mortality rate indicated favourable outcomes for kidney transplant recipients in this low-resource setting comparable to those in developed nations. The hospital's six-year experience demonstrates the feasibility of establishing and maintaining KT services in low-income countries.
期刊介绍:
BMC Nephrology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.